Q2 2025 Aarti Drugs Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Aarti Drugs Limited Q2 FY25 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict.
(Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Adhish Patil, CFO and CEO. Thank you, and over to you, sir.
Thank you. Good morning and a warm welcome to everyone present on the conference call of Aarti Drugs Limited.
On this call, we are joined by Mr. Harshit Savla, Joint Managing Director; Mr. Harit Shah, whole-time Director of Aarti Drugs Limited; and Mr. Vishwa Savla, he won't be in the call; and SGA, our Investor Relations Advisor. I hope everyone had an opportunity to go through the financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |